• US: +1 9176726599
  • Login

Gene Editing Market Size By Technology Coverage ( Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector-based Nucleases (TALENs), CRISPR-Cas9 Gene Editing, Restriction Enzymes, Others), By Application Coverage( Gene editing, Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Drug development, Others), By End User and Region Forecast to 2023-2032

Format: PDF | Pages: 303 | Report ID: MRS1258


Report Description

The global Gene Editing market size was valued at USD 5,308.1 million in 2022, expanding at a CAGR of 18.3% from 2023-2032 to reach 21,008.7 Million USD in 2032.

Market Dynamics

The Gene Editing market is expected to witness substantial growth over the forecast period. The term "gene editing" (sometimes referred to as "genome editing") describes a group of technologies that enable researchers to change an organism's DNA. At precise locations in the genome, these technologies enable the addition, deletion, or change of genetic material. Numerous methods for genome editing have been developed. The field of genome editing is gaining substantial attention for its potential to prevent and cure human diseases. To better understand disorders, the majority of genome editing research is being carried out using cell and animal models. Researchers are still attempting to determine whether this procedure is secure and effective in people. It is being researched for a variety of illnesses, including single-gene diseases such as sickle cell anemia, hemophilia, and cystic fibrosis.

The growth of the gene editing market is being driven by the rising demand for synthetic genes in both developed and developing countries. There are various fields of application for genomics, including the identification of genetic disorders in humans, drug discovery, agriculture, veterinary science, and forensics. Due to technologies created by Illumina expressly for forensic research, the use of genomics in forensic investigations has significantly increased with the introduction of next-generation sequencing (US). While DNA analysis was traditionally used for fingerprint profiling, NGS helps with the analysis of a specimen found at the scene of a crime and enables the extraction of greater amounts of information from a trace or a damaged DNA sample.

Testing for food safety and quality is increasingly using genetics. Genome editing technology is essential for drug development, human genetic abnormality identification, and treatment. Genome editing is used in NGS, DNA analysis, and profiling, as well as in plant and animal genetic engineering. Future trends in genomic engineering include use in marine engineerings, such as the production of nutraceuticals from algae. Two more recent applications are in forensic sciences and personalized medicine. When evaluating fish populations, NGS can be utilized for DNA barcoding to identify fish larvae and eggs as well as provide a thorough description of fish communities. The use of genomic testing to determine the safety and quality of food is spreading. The creation of new drugs frequently makes use of genome editing techniques.

Regional Insights

Due to the rise in the prevalence of rare illnesses, North America, which held the largest market share in 2022, is anticipated to have considerable growth over the coming years. Between 25 and 30 million Americans are affected by about 7,000 uncommon diseases, according to the National Institutes of Health (NIH).

Due to the use of novel technologies and techniques for gene editing, there is a greater need for medicine development to treat rare disorders. Additionally, the presence of major industry players in North America will promote market expansion for gene editing. The development of practical materials, tools, and procedures was financed by more than 20 federal agencies in the United States.

Segment Dynamics

The Gene Editing market is fragmented into technology, applications, and end-user segments. Based on the technology, the zinc finger nucleases segment is anticipated to dominate the market. By application, the gene editing segment of the market is projected to grow at the highest CAGR (Compounded annual growth rate) during the forecast period. By end-user, the biotechnology, and pharmaceutical companies segment is expected to hold the majority of the market share.

Competitive Insights

The Gene Editing market is highly competitive in nature with the presence of local & international players. Major players in the industry engage in strategic mergers & acquisitions, partnerships, and new product launches to remain competent in the market. As an illustration, Allele Biotechnology and Alpine BioTherapeutics Corporation entered into an agreement in June 2022 to create induced pluripotent stem cells for the treatment of retinal diseases. This collaboration helped the company to expand its product portfolio and offer cutting-edge solutions.

The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses the market size and forecast of Gene Editings by type describes the industry environment, then analyses the introduces the market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

  • Addgene
  • Allele Biotech
  • Bio-Rad
  • Takara Bio
  • CRISPR Therapeutics
  • OriGene Technologies
  • Precision Biosciences
  • GE Healthcare
  • Merck KGaA
  • ThermoFischer Scientific Inc.

Technology Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Zinc Finger Nucleases (ZFNs)
  • Transcription Activator-Like Effector-based Nucleases (TALENs)
  • CRISPR-Cas9 Gene Editing
  • Restriction Enzymes
  • Others

Application Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Gene editing
  • Cell Line Engineering
  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Drug development
  • Others

End User Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations

Region Coverage (Regional Consumption, Demand & Forecast by Countries etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

Frequently Asked Questions

The global Gene Editing market size was valued at USD 5,308.1 million in 2022, expanding at a CAGR 18.3% from 2023-2030 to reach 21,008.7 Million USD in 2030.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global Gene Editing market size is expanding at a CAGR 18.3% from 2023-2030 to reach 21,008.7 Million USD in 2030.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The Gene Editing market is highly competitive in nature with the presence of local & international players. Major players in the industry engage in strategic merger & acquisition, partnership, and new product launches to remain competent in the market. As an illustration, Allele Biotechnology and Alpine BioTherapeutics Corporation entered into an agreement in June 2021 to create induced pluripotent stem cells for the treatment of retinal diseases. This collaboration helped the company to expand its product portfolio and offer cutting-edge solutions.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.